Clinical Report: Transdermal NSAID Matches Oral Celecoxib After Knee Replacement
Overview
A transdermal esflurbiprofen patch demonstrated noninferior pain control compared to oral celecoxib in patients post-total knee arthroplasty. Both treatments resulted in similar pain scores, functional recovery, and safety outcomes over a 6-week follow-up period.
Background
Post-operative pain management is critical for recovery following total knee arthroplasty (TKA). Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain control. This study addresses the role of a transdermal esflurbiprofen patch in comparison to oral celecoxib.
Data Highlights
| Measure | Transdermal Esflurbiprofen | Oral Celecoxib |
|---|---|---|
| Pain at Rest (POD 14) | 1.0 | 0.8 |
| Pain with Movement (POD 14) | 2.5 | 2.3 |
| Pain at Rest (Week 6) | 0.6 | 0.5 |
| Pain with Movement (Week 6) | 2.0 | 1.8 |
Key Findings
- The transdermal esflurbiprofen patch provided pain control comparable to oral celecoxib.
- Average pain scores at rest and during movement improved significantly in both groups.
- Functional recovery measures showed no significant differences between the two treatment groups.
- No patients required rescue morphine in either group.
- Safety outcomes, including kidney function, were similar across both treatments.
Clinical Implications
The findings suggest that transdermal esflurbiprofen can be an effective alternative to oral celecoxib for managing post-operative pain in TKA patients. This may provide clinicians with additional options for multimodal pain management strategies.
Conclusion
Transdermal esflurbiprofen matches oral celecoxib for post-operative pain control in total knee arthroplasty.
Related Resources & Content
- Comparison of transdermal and oral anti-inflammatory drugs on immediate post-operative pain control in total knee arthroplasty: a randomized controlled trial | Arthroplasty | Springer Nature, 2026 -- Transdermal NSAID Matches Oral Celecoxib After Knee Replacement
- Prednisolone May Reduce Early Pain After TKA, 2026 -- Prednisolone May Reduce Early Pain After TKA
- Evaluating Cardiovascular Risks Associated with Non-steroidal Anti-inflammatory Medications: Implications for Clinical Practice, 2014 -- Evaluating Cardiovascular Risks Associated with Non-steroidal Anti-inflammatory Medications
- Ophthalmology Management — Rx Perspective - Using NSAIDs to Full Potential Recommendations
- Contact Lens Spectrum — treatment plan
- Comparison of transdermal and oral anti-inflammatory drugs on immediate post-operative pain control in total knee arthroplasty: a randomized controlled trial | Arthroplasty | Springer Nature Link
- Non-Opioid Analgesics for Postoperative Pain Management Following Total Joint Arthroplasty: A Systematic Review and Meta-Analysis - ScienceDirect
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
